Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Dailiport
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dailiport 1mg modified-release capsules
0802020T0BKABAN
|
Dailiport | Tacrolimus | Malignant Disease and Immunosuppression | 43 |
|
Dailiport 0.5mg modified-release capsules
0802020T0BKAAAM
|
Dailiport | Tacrolimus | Malignant Disease and Immunosuppression | 12 |
|
Dailiport 3mg modified-release capsules
0802020T0BKACAT
|
Dailiport | Tacrolimus | Malignant Disease and Immunosuppression | 5 |
|
Dailiport 2mg modified-release capsules
0802020T0BKAEBJ
|
Dailiport | Tacrolimus | Malignant Disease and Immunosuppression | 4 |
|
Dailiport 5mg modified-release capsules
0802020T0BKADAP
|
Dailiport | Tacrolimus | Malignant Disease and Immunosuppression | 1 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.